Post-COVID pulmonary fibrosis, which involves scarring of the lungs that can worsen over time and may require a lung transplant, affects some patients after infection, according to pulmonologists.

Researchers at Baylor College of Medicine and collaborating institutions have uncovered a key molecular player that is involved in lung repair and in the development of pulmonary fibrosis, a common ...

A common over-the-counter ingredient in many cough syrups may have a greater purpose for people suffering from lung fibrosis that is related to any number of serious health conditions.

Lung fibrosis – caused by an excess amount of scarring, formed when fibrillar collagen accumulates in the lung – most often occurs in older adults for a variety of reasons: exposure to ...

Novel pathway has potential to slow progression of pulmonary fibrosis Date: March 25, 2025 Source: Elsevier Summary: Researchers have found a potential new way to slow the progression of lung ...

So, the researchers obtained lung cells from a volunteer who has cystic fibrosis and cultured them in a way to form a three-dimensional tissue. These cultures were then exposed to SORT particles ...

VIENNA — Treatment with a novel lysophosphatidic acid receptor 1 (LPA1) antagonist was associated with significant changes in baseline biomarkers of disease in adults with pulmonary fibrosis ...

Health Lung-targeted CRISPR therapy offers hope for cystic fibrosis Gene therapies for cystic fibrosis have previously struggled to reach the faulty lung cells, but a new approach has succeeded in ...